
Explore the fundamentals of clinical research, including therapeutic and non-therapeutic studies, informed consent, ethical safeguards, and the phase-wise trial process from protocol to licensing.
Trace the evolution of U.S. drug law. Learn key milestones from the United States Pharmacopeia to the 1938 Federal Food, Drug and Cosmetic Act and beyond.
Explore the FDA drug approval process from drug development and animal testing to NDA review. Learn about IND, phase one through phase three trials, labeling, facility inspection, and post-marketing surveillance.
Explore preclinical steps in new drug development, including in vivo and in vitro studies, toxicity and safety evaluation, target identification, and formulation planning under GLP.
Learn how the investigational new drug application (INDA) to the FDA enables initiating clinical studies, and distinguish commercial from non-commercial INDs, including investigators, emergency use, and treatment INDs.
Explain the four nda pathways—nda, bla, 505(b)(2), and sNDA—and the nda process from data submission to the fda, including the common technical document format, labeling, inspections, and potential approvals.
Explore the ANDA process, patent protections, and exclusivity provisions under the Hatch-Waxman Act, including bioequivalence, cGMP requirements, and the 18–24 month generic drug development timeline.
Navigate para four certification in ANDA filings, complete 20 days' notice after confirmation, sue within 45 days, endure a 30 months stay, and secure 180 days exclusivity.
Understand the abbreviated new drug application (ANDA) process, submitting to the FDA in CTD format, and assess pharmaceutical and therapeutic equivalence and bioequivalence to the reference listed drug.
Examine generic product subcategories, including ordinary generics, value-added generics, new delivery systems, biogenerics, branded generics, patent-expired molecule reformulations, line extensions, retargeting, and new products in the generics segment.
Compare innovated and generic drug products across quality system, efficacy, manufacturing, excipients, competition, price, packaging, promotion, product development time, purity, and marketing authorization (MAA).
Compare innovator and generic drugs on availability, cGMP, stability, safety and regulatory compliance, approval time, brand name, steps skipped, and manufacturing cost.
Compare NDA and ANDA in the regulatory review, covering common points like labeling, pharmacology/toxicology data, CMC, site inspections, testing and microbiological data, with differentiating needs for bioavailability and bioequivalence data.
Learn how inclusion and exclusion criteria identify suitable participants for clinical trials, covering age, gender, informed consent, health status, and factors like pregnancy, concurrent illness, and toxicity risk.
Clinical research involves sponsors, investigators, CRA, coordinators, data managers, statisticians, patients, IRB, regulatory bodies; each stakeholder protects rights and well-being and ensures compliance with ICH-GCP guidelines, SOPs, and protocols.
The sponsor ensures clinical trial quality with a quality plan and system, defines organizational setup and responsibilities, oversees regulatory compliance, protocol adherence, CRO relationships, data handling, and written agreements.
Select qualified investigators with adequate resources and define duties to ensure trial success. Provide protocol and investigator brochure, coordinate regulatory submissions, and ensure approvals and consent processes.
Supply investigational products to sites and investigators, ensure timely delivery and stability, maintain cost controls and disposition, and oversee safety reporting, monitoring, auditing, and regulatory submissions.
define the investigator's role as the trial leader with required qualifications and resources. ensure protocol compliance, subject medical care, informed consent, and proper reporting of deviations.
Accountability of the investigational product lies with investigator or institution. Maintain records, inventory, and disposition; follow randomization and unblinding procedures; obtain informed consent; ensure records integrity and sponsor protocol adherence.
Investigators must submit annual progress reports to the IAB, sponsor, and institution, report serious adverse events promptly, and maintain accurate source records per GCP.
Identify the responsibilities of a clinical research associate and clinical research coordinator, from sponsor-site liaison and document handling to site selection, data collection and reporting, and timely trial initiation.
Identify essential documents that demonstrate trial conduct quality and data integrity, organized in the trial master file, site master file, and regulatory records, covering pre, during, and post trial stages.
Identify and manage essential trial documents added during the conduct, including protocol amendments, informed consent, subject recruitment advertisement (if used), regulatory approvals, investigator CVs, investigational product accountability, and safety information.
Outline the clinical trial protocol as the study's objectives, design, eligibility, methodology, and statistical considerations to safeguard participants and answer key questions.
Source documents are original data and records—hospital records, lab notes, diaries, pharmacy records, automated data, X-rays—that create a clean, verifiable audit trail of drug administration and medical events.
Practice informed consent as a comprehensive ethical process rooted in the Nuremberg Code, focusing on voluntariness, thorough information, and ongoing discussion with FDA 21 CFR Part 50 guidelines.
Explore additional informed consent elements, including withdrawal and termination, subject costs, notification to representatives, risks to fetuses, and situations requiring IRB guidance for incompetence or illiteracy.
The investigator's brochure compiles nonclinical and clinical data on the investigational product, informing investigators and regulators about safety, adverse events, pharmacokinetics, and study progression.
Understand how patient information brochures explain clinical trials in simple language for lay participants, covering purpose, participation, benefits, risks, and trial methods, plus translation, arm allocation, and regulatory review.
Learn how case report forms drive data integrity in clinical trials, detailing paper and electronic CRFs, essential fields, quality checks, and regulatory considerations for safe data sharing.
Master meeting etiquette by valuing time, arriving punctually, and presenting a professional appearance. Greet confidently, avoid mobile distractions, stand when introduced, adjust seating, and acknowledge introductions.
Develop confident communication in meetings by maintaining eye contact, not interrupting, and taking notes. Ask relevant questions at the right time and share agendas in advance.
Celebrate completing the certificate course in clinical research; summarize key concepts, invite feedback, and guide learners to download their certificate (PDF or JPG) and connect on LinkedIn and Twitter.
If you find the Clinical Research field challenging, well, in that case, this is the best course for you.
The pharmaceutical industry is one of the extremely regulated industries, with several government regulations to protect public health. Therefore, the important target of the pharmaceutical industry is to develop a Drug product passing the regulatory requirements. On the other hand, regulation of drug development, manufacturing, marketing, and sales involves paradoxical objectives. It must ensure that safe and effective pharmaceutical formulations reach the public quickly while concurrently protecting against ineffective/unsafe/harmful therapies. This course will provide you with a strong understanding of the Drug development process, Clinical Research and related documents, GCP, Roles, and responsibilities of major players in Clinical Research in a summarized manner which will help to work towards shaping your career in Clinical Research.
This course focuses on the following points that could make Clinical Research activities smooth without any significant delays/failures,
• Basic Understanding of Clinical Research,
• Major players in Clinical Research,
• Historical background of US Drug Law and Regulations,
• Drug Approval Process,
• New Drug Development-Preclinical Steps
• Investigational New Drug Application (INDA),
• New Drug Application (NDA),
• Abbreviated New Drug Application (ANDA),
• Essential Documents,
• Protocol,
• Source Documents,
• Informed Consent form,
• Investigator’s Brochure,
• Case Report Form (CRF),
• Inclusion-Exclusion criteria,
• Sponsor,
• Investigator,
• Clinical Research Associate (CRA) and Clinical Research Coordinator (CRC),
• Important Literature Search Websites for Clinical Research Professional,
• Many more...
There will be several downloadable documents so that you can follow along with them whenever you need them.
This course contains Commonly Asked Questions that will help you while preparing for Clinical Research interviews.
Last but not the least, this course also contains a bonus course entitled "Meeting etiquettes" which will help you to shape your career in which the points that must be taken into consideration while attending/conducting meetings are covered.
In this course, more than 30 informative videos are included and are designed in an easily digestible format and going to take you through step by step approach to understand Clinical Research and relevant activities.
I believe "Quality improvement is a continuous and lifetime process". Upon completion of this course, you will be a whole different professional with improved Clinical Research knowledge which will help you to garner more respect from your team members, managers, clients, or anyone with whom you are communicating/interacting.